Let's Short This Duffer Out Of Business

Div -
see this:
At the end of December 2001, cash balances stood at 15.3 mln stg, sufficient to
fund the group's products through to their next clinical milestones in 2003'
- They are burning cash at around 8M per year I believe but I dont have that exact.
IF they fail to increase revenue in 2003 they will need to fund-raise .
If deals are late in 2003 this could bring out predatory attitudes in the would be partners of the treatment or whatever.
I rate these as exciting in 2003 but with some risk. Maybe they should merge with BBG and its 43 M quid?
That could guarantee the future of both parties? I'm serious, not ramping or deramping. It could be the making of both companies.
I hold BBG stock, not preently AZM.
H